At a glance
ClinicalIndex Comparison RecordN/ACompleted· 142 enrolled
Drug / intervention
Continuous Glucose Monitor (CGM)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CGM Use in Hospitalized Patients With Diabetes Mellitus
In Brief
A clinical study evaluating Continuous Glucose Monitor (CGM) for Diabetes Mellitus. Completed, enrolled 142 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if patient's own Continuous Glucose Monitor (CGMs) worn in the non-ICU hospital setting have adequate accuracy for blood glucose monitoring when compared to point-of-care (POC) capillary glucose measurement, and to determine if alerts given by CGMs worn in the non-ICU hospital would prevent episodes of hyperglycemia and hypoglycemia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartJan 2021
Primary CompletionNov 2023
TodayJul 2026
First PostedDec 4, 2020
Enrollment StartJan 1, 2021
Primary CompletionNov 10, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 5.6 years ago
Interventions
Continuous Glucose Monitor (CGM)device
CGM data will be downloaded prior to discharge and it will be compared with hospital glucometer readings taken at the same time.